Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02308098Phase 3Completed
A Phase 3 trial of budesonide + formoterol in asthma, sponsored by Orion Corporation. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02308098.